Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:10501568rdf:typepubmed:Citationlld:pubmed
pubmed-article:10501568lifeskim:mentionsumls-concept:C2349001lld:lifeskim
pubmed-article:10501568lifeskim:mentionsumls-concept:C0681850lld:lifeskim
pubmed-article:10501568lifeskim:mentionsumls-concept:C1706203lld:lifeskim
pubmed-article:10501568lifeskim:mentionsumls-concept:C2697811lld:lifeskim
pubmed-article:10501568lifeskim:mentionsumls-concept:C0162783lld:lifeskim
pubmed-article:10501568lifeskim:mentionsumls-concept:C0005586lld:lifeskim
pubmed-article:10501568lifeskim:mentionsumls-concept:C0027893lld:lifeskim
pubmed-article:10501568lifeskim:mentionsumls-concept:C1515670lld:lifeskim
pubmed-article:10501568lifeskim:mentionsumls-concept:C0392756lld:lifeskim
pubmed-article:10501568lifeskim:mentionsumls-concept:C1550501lld:lifeskim
pubmed-article:10501568pubmed:issue8lld:pubmed
pubmed-article:10501568pubmed:dateCreated1999-11-15lld:pubmed
pubmed-article:10501568pubmed:abstractTextIn the present study, we compared neuropeptide Y mRNA expression levels in the prefrontal cortex (Brodmann area 9 and 46) of subjects diagnosed with major depression, bipolar disorder and schizophrenia with those in normal controls without a psychiatric history. No correlation was found regarding neuropeptide Y mRNA expression and postmortem interval, age, gender, hemisphere side, suicide as cause of death, or the history of use of substances such as alcohol, marihuana and cocaine/amphetamine. The only significant alteration found was related to the clinical diagnosis; neuropeptide Y mRNA expression was reduced in the group of bipolar subjects as compared to the controls. Overall, the present results confirm an involvement of neuropeptide Y in affective disorders, and show for the first time a specific association between NPY and bipolar disorder.lld:pubmed
pubmed-article:10501568pubmed:languageenglld:pubmed
pubmed-article:10501568pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10501568pubmed:citationSubsetIMlld:pubmed
pubmed-article:10501568pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10501568pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10501568pubmed:statusMEDLINElld:pubmed
pubmed-article:10501568pubmed:monthJunlld:pubmed
pubmed-article:10501568pubmed:issn0959-4965lld:pubmed
pubmed-article:10501568pubmed:authorpubmed-author:HurdY LYLlld:pubmed
pubmed-article:10501568pubmed:authorpubmed-author:CaberlottoLLlld:pubmed
pubmed-article:10501568pubmed:issnTypePrintlld:pubmed
pubmed-article:10501568pubmed:day3lld:pubmed
pubmed-article:10501568pubmed:volume10lld:pubmed
pubmed-article:10501568pubmed:ownerNLMlld:pubmed
pubmed-article:10501568pubmed:authorsCompleteYlld:pubmed
pubmed-article:10501568pubmed:pagination1747-50lld:pubmed
pubmed-article:10501568pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:10501568pubmed:meshHeadingpubmed-meshheading:10501568...lld:pubmed
pubmed-article:10501568pubmed:meshHeadingpubmed-meshheading:10501568...lld:pubmed
pubmed-article:10501568pubmed:meshHeadingpubmed-meshheading:10501568...lld:pubmed
pubmed-article:10501568pubmed:meshHeadingpubmed-meshheading:10501568...lld:pubmed
pubmed-article:10501568pubmed:meshHeadingpubmed-meshheading:10501568...lld:pubmed
pubmed-article:10501568pubmed:meshHeadingpubmed-meshheading:10501568...lld:pubmed
pubmed-article:10501568pubmed:meshHeadingpubmed-meshheading:10501568...lld:pubmed
pubmed-article:10501568pubmed:meshHeadingpubmed-meshheading:10501568...lld:pubmed
pubmed-article:10501568pubmed:meshHeadingpubmed-meshheading:10501568...lld:pubmed
pubmed-article:10501568pubmed:meshHeadingpubmed-meshheading:10501568...lld:pubmed
pubmed-article:10501568pubmed:meshHeadingpubmed-meshheading:10501568...lld:pubmed
pubmed-article:10501568pubmed:meshHeadingpubmed-meshheading:10501568...lld:pubmed
pubmed-article:10501568pubmed:meshHeadingpubmed-meshheading:10501568...lld:pubmed
pubmed-article:10501568pubmed:meshHeadingpubmed-meshheading:10501568...lld:pubmed
pubmed-article:10501568pubmed:meshHeadingpubmed-meshheading:10501568...lld:pubmed
pubmed-article:10501568pubmed:year1999lld:pubmed
pubmed-article:10501568pubmed:articleTitleReduced neuropeptide Y mRNA expression in the prefrontal cortex of subjects with bipolar disorder.lld:pubmed
pubmed-article:10501568pubmed:affiliationKarolinska Institute, Department of Clinical Neuroscience, Karolinska Hospital, Stockholm, Sweden.lld:pubmed
pubmed-article:10501568pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:10501568pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10501568lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10501568lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10501568lld:pubmed